For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
TruePath: A Powerful new solution for intraluminal treatment of chronic total occlusions.
|Shaping Tool||Motor Housing||Control Unit|
|H74939208181650||39208-18165||TruePath CTO Device|
|H74939208001601||39208-00160||TruePath Extension Wires (5/box)|
|Size (OD)||Length||Sheath Compatibility||Min. Guide Catheter ID||Tip Profile|
|0.018" / 0.46 mm||165 cm||≥ 0.018" / 0.46 mm compatible Catheters¹||≥ 0.018" / 0.46 mm||0.017" / 0.43 mm|
Demonstrate that TruePath CTO Device is safe and effective to facilitate crossing infrainguinal artery CTOs following resistance to crossing with a conventional guidewire or a prior failed attempt.
- 85 Subjects
- 3 centers in Europe
|Key Clinical Results|
|All Patients: (n=85)|
|Freedom from clinical perforation (any perforation requiring treatment) of the index lesion to 30 days||98.8% (*84/85)|
|Facilitation of crossing the CTO with the TruePath CTO Device and/or any guidewire||80.0% (68/85)|
|Length of Occlusion||< 100 mm||38.8%|
|101 mm – 200 mm||30.6%|
|201 mm – 450 mm||30.6%|
|Mean Length of Occlusion||166.0 mm|